Developer docs
API playgroundTry for free, no card

Search company profiles

Heaton Group

Full company profile

uuid003ngd3

Namestring
Heaton Group
Legal namestring
HEATON k.s.
Websiteurl
heaton.cz
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Heaton Group is a privately-held Czech pharmaceutical company founded in 2002 and headquartered in Prague. It supplies pharmaceuticals and medical devices across five therapeutic areas — gynecology, urology, nephrology, oncology, and diabetology — and also markets cosmetics and foods for special medical purposes. The company is wholly family-owned by the Frič family (no external investors), operates through a Czech holding structure (HEATON k.s.) created in 2012, and is run by the founders' children: Managing Director Jaromír Frič Jr. and Business Development Director Natálie Kazíková.

The portfolio rests on two proprietary technology platforms: a tyndallization process that produces the first vaginal paraprobiotic preserving whole-cell immunogenic structure, and the patented TIAB complex (titanium dioxide microcrystals with bound silver ions) delivering antimicrobial, barrier, and regenerative effects. The OTC women's health franchise is marketed under the GYNELLA sub-brand and spans intimate hygiene, vaginal infections, atrophy, fertility support, and cystitis; Heaton also holds more than 30 marketing authorizations for prescription medicines and distributes foods for special medical purposes. Distribution combines owned field-sales forces in Czech Republic, Germany, Slovakia, and Romania with distribution partners covering 30+ additional countries, anchored by wholly-owned subsidiaries in those four European markets plus a Singapore subsidiary opened in October 2024 as an APAC gateway.

The business model is a hybrid licensing-distribution model: Heaton partners with active-substance manufacturers for product licensing, maintains its own marketing authorizations and ISO/GMP/GDP certifications, and generates revenue through pharmacy-channel OTC sales, prescription-medicine promotion via medical representatives, and direct-to-consumer e-commerce through the GYNELLA storefront. Customer segments split between prescribing healthcare professionals (gynecologists, urologists, oncologists, diabetologists) for Rx products and female end-consumers for the OTC line. Geographic exposure is concentrated in Central and Eastern Europe with growing Western European and nascent APAC reach.

Short descriptiontext

Heaton Group is a family-owned Czech pharmaceutical company that develops, licenses, and distributes prescription medicines, OTC medical devices (GYNELLA brand), cosmetics, and foods for special medical purposes across gynecology, urology, nephrology, oncology, and diabetology, serving healthcare professionals and female consumers in 27+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPrague, Czechia
HQ citystring
Prague
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, medical devices, women's health, prescription medicines, gynecological therapeutics
Industry4 codes
PRIMARYHLAIADAJ
Women’s Health (OTC Gynecologic)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAK
Men’s Health (OTC Urologic & Sexual Health)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)
SECONDARYCRADAMAH
Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Pharmaceutical Products
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Medicines
TypeOne Time License
Description

Heaton holds over 30 marketing authorizations for prescription medicines across therapeutic areas including gynecology, urology, nephrology, oncology, and substitution treatment. Products are promoted through medical representatives.

heaton.cz
2Medical Devices (OTC)
TypeOne Time License
Description

OTC medical devices sold in pharmacies under the GYNELLA brand including Silver Caps, Silver Foam, Flora, Balance, AtroGel, Natal Ferti Gel, and intimate hygiene products. Available without prescription.

heaton.cz
3Cosmetics
TypeOne Time License
Description

Cosmetic products under the GYNELLA brand for intimate hygiene.

heaton.cz
4Foods for Special Medical Purposes
TypeOne Time License
Description

Specialized nutritional products for specific medical conditions.

heaton.cz
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1GYNELLA
Description

OTC brand covering intimate hygiene, vaginal infections, vaginal atrophy, fertility, and vaginal microflora products including GYNELLA Flora, GYNELLA Balance, GYNELLA AtroGel, GYNELLA Natal Ferti Gel, GYNELLA Silver Caps, GYNELLA Silver Foam, GYNELLA Intimate Foam, GYNELLA Intimate Wash, GYNELLA Girl Intimate Wash, and GYNELLA Cystilab.

heaton.cz
+2 more records
Core offering1 text field

Heaton Group supplies prescription pharmaceuticals and OTC medical devices across therapeutic areas including gynecology, urology, nephrology, oncology, diabetology, and hospital care. The company holds more than 30 marketing authorizations for prescription medicines and operates the GYNELLA brand of OTC women's health medical devices (Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, intimate hygiene line), along with cosmetics and foods for special medical purposes. Products are sold in 27 countries through owned sales teams, subsidiaries, and a network of international distribution partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • GYNELLA brand launched successfully in 7 European countries
+1 more record
Product overview1 text field

Heaton Group is an international pharmaceutical company headquartered in Prague, Czech Republic, operating as a privately-owned enterprise. The company offers a diversified portfolio consisting of: (1) Prescription Medicines – more than 30 marketing authorizations covering gynecology, urology, nephrology, oncology, substitution treatment, and hospital care segments; (2) Medical Devices – the core GYNELLA® product line for women's health including GYNELLA® Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, Intimate Foam, Intimate Wash, Girl Intimate Wash, plus ATUCARE, VREYA, and ANDRYLL Silver Gel; and (3) Cosmetics within the GYNELLA brand. The GYNELLA® products form the primary OTC medical device portfolio focused on gynecological applications including vaginal infections, vaginal atrophy/dryness, vaginal microbiota support, fertility, and intimate hygiene. The company operates through its own sales teams in Czech Republic, Germany, Slovakia, and Romania, with distribution partnerships extending to 27+ countries including the new Singapore subsidiary.

Product and service1 record
1GYNELLA Flora
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-term partnerships with manufacturers of active substances for product licensing. These partnerships enable Heaton to offer a state-of-the-art portfolio with large production capacity across various pharmaceutical forms including tablets, capsules, gels, foams, and injectable solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International distribution partners operating in various territories with exclusivity arrangements. Current partners cover countries including Austria, Bulgaria, Croatia, Czech Republic, Denmark, UAE, Germany, Malta, Mongolia, Norway, Moldova, Pakistan, Romania, Slovakia, Slovenia.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-headquartered OTC consumer healthcare leader with strong presence in Europe. Direct overlap with Heaton's OTC medical device and women's health positioning through pharmacy distribution.

TypeBroad incumbent
Description

Global women's health pure-play spun out of Merck in 2021, focused on contraception, fertility, and menopause. Directly addresses the same therapeutic categories as Heaton but at much greater scale and global footprint.

TypeRegional player
Description

Polish pharmaceutical manufacturer and one of the largest CEE pharma players. Similar mix of Rx and OTC products, comparable CEE-centric distribution model, and overlapping therapeutic areas including women's health and urology.

TypeDirect peer
Description

Slovenian-headquartered generic and specialty pharmaceutical company with broad CEE distribution. Comparable scale and origin to Heaton, with overlapping presence in gynecology, urology, and over-the-counter women's health categories.

5Bayer Consumer Health
TypeBroad incumbent
Description

Global consumer health giant encompassing OTC, women's health, and intimate care products. Heaton's GYNELLA cosmetics/hygiene range overlaps with Bayer's broad feminine care portfolio, though Bayer operates at vastly larger scale.

TypeDirect peer
Description

Hungarian-headquartered pharma company with a major women's health franchise (contraception, fertility, menopause). Comparable to Heaton due to CEE origin, prescription + women's health focus, and similar European distribution model.

TypeDirect peer
Description

UK-headquartered specialty pharmaceutical company exclusively focused on women's health (contraception, fertility, menopause, osteoporosis). Closely comparable as a niche women's health player with similar product categories and OTC/Rx split.

TypeDirect peer
Description

German-headquartered pharma company with strong generics, specialty, and consumer health businesses. Comparable in European geographic focus and mix of prescription and OTC consumer products including intimate care.

TypeBroad incumbent
Description

Italian specialty pharmaceutical company with strong franchises in urology, gynecology, and rare disease. Comparable in therapeutic focus and geographic mix (European roots expanding globally).

TypeEmerging player
Description

Austrian pharmaceutical company specializing in aesthetic medicine, gynecology, and orthopedics with focus on hyaluronic acid-based products. Comparable niche women's health focus and overlapping technology ingredient (hyaluronic acid used in Heaton's GYNELLA AtroGel and Balance).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Heaton Group

Pharmaceutical Productsheaton.cz

Heaton Group is a family-owned Czech pharmaceutical company that develops, licenses, and distributes prescription medicines, OTC medical devices (GYNELLA brand), cosmetics, and foods for special medical purposes across gynecology, urology, nephrology, oncology, and diabetology, serving healthcare professionals and female consumers in 27+ countries.

What Heaton Group does

Heaton Group is a privately-held Czech pharmaceutical company founded in 2002 and headquartered in Prague. It supplies pharmaceuticals and medical devices across five therapeutic areas — gynecology, urology, nephrology, oncology, and diabetology — and also markets cosmetics and foods for special medical purposes. The company is wholly family-owned by the Frič family (no external investors), operates through a Czech holding structure (HEATON k.s.) created in 2012, and is run by the founders' children: Managing Director Jaromír Frič Jr. and Business Development Director Natálie Kazíková.

The portfolio rests on two proprietary technology platforms: a tyndallization process that produces the first vaginal paraprobiotic preserving whole-cell immunogenic structure, and the patented TIAB complex (titanium dioxide microcrystals with bound silver ions) delivering antimicrobial, barrier, and regenerative effects. The OTC women's health franchise is marketed under the GYNELLA sub-brand and spans intimate hygiene, vaginal infections, atrophy, fertility support, and cystitis; Heaton also holds more than 30 marketing authorizations for prescription medicines and distributes foods for special medical purposes. Distribution combines owned field-sales forces in Czech Republic, Germany, Slovakia, and Romania with distribution partners covering 30+ additional countries, anchored by wholly-owned subsidiaries in those four European markets plus a Singapore subsidiary opened in October 2024 as an APAC gateway.

The business model is a hybrid licensing-distribution model: Heaton partners with active-substance manufacturers for product licensing, maintains its own marketing authorizations and ISO/GMP/GDP certifications, and generates revenue through pharmacy-channel OTC sales, prescription-medicine promotion via medical representatives, and direct-to-consumer e-commerce through the GYNELLA storefront. Customer segments split between prescribing healthcare professionals (gynecologists, urologists, oncologists, diabetologists) for Rx products and female end-consumers for the OTC line. Geographic exposure is concentrated in Central and Eastern Europe with growing Western European and nascent APAC reach.

Heaton Group firmographics

Firmographics
Name
Heaton Group
Legal name
HEATON k.s.
Website
https://heaton.cz
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Heaton Group is a family-owned Czech pharmaceutical company that develops, licenses, and distributes prescription medicines, OTC medical devices (GYNELLA brand), cosmetics, and foods for special medical purposes across gynecology, urology, nephrology, oncology, and diabetology, serving healthcare professionals and female consumers in 27+ countries.
Ownership category
akta.pro rank

Heaton Group industry classification

Industry
Product category
Pharmaceutical Products
NAICS
Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYHLAIADAJ
Women’s Health (OTC Gynecologic)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAK
Men’s Health (OTC Urologic & Sexual Health)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)
SECONDARYCRADAMAH
Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Pharmaceutical products
  • Medical devices
  • Women's health
  • Prescription medicines
  • Gynecological therapeutics

Where Heaton Group is headquartered

Location

Headquarters

HQ city
Prague
HQ country
Czechia
HQ region
Europe

Offices5 records

Markets served

Heaton Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

  1. Prescription Medicines: Heaton holds over 30 marketing authorizations for prescription medicines across therapeutic areas including gynecology, urology, nephrology, oncology, and substitution treatment. Products are promoted through medical representatives.
  2. Medical Devices (OTC): OTC medical devices sold in pharmacies under the GYNELLA brand including Silver Caps, Silver Foam, Flora, Balance, AtroGel, Natal Ferti Gel, and intimate hygiene products. Available without prescription.
  3. Cosmetics: Cosmetic products under the GYNELLA brand for intimate hygiene.
  4. Foods for Special Medical Purposes: Specialized nutritional products for specific medical conditions.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Heaton Group product offering

Product offering

Core offering

Heaton Group supplies prescription pharmaceuticals and OTC medical devices across therapeutic areas including gynecology, urology, nephrology, oncology, diabetology, and hospital care. The company holds more than 30 marketing authorizations for prescription medicines and operates the GYNELLA brand of OTC women's health medical devices (Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, intimate hygiene line), along with cosmetics and foods for special medical purposes. Products are sold in 27 countries through owned sales teams, subsidiaries, and a network of international distribution partners.

Product overview

Heaton Group is an international pharmaceutical company headquartered in Prague, Czech Republic, operating as a privately-owned enterprise. The company offers a diversified portfolio consisting of: (1) Prescription Medicines – more than 30 marketing authorizations covering gynecology, urology, nephrology, oncology, substitution treatment, and hospital care segments; (2) Medical Devices – the core GYNELLA® product line for women's health including GYNELLA® Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, Intimate Foam, Intimate Wash, Girl Intimate Wash, plus ATUCARE, VREYA, and ANDRYLL Silver Gel; and (3) Cosmetics within the GYNELLA brand. The GYNELLA® products form the primary OTC medical device portfolio focused on gynecological applications including vaginal infections, vaginal atrophy/dryness, vaginal microbiota support, fertility, and intimate hygiene. The company operates through its own sales teams in Czech Republic, Germany, Slovakia, and Romania, with distribution partnerships extending to 27+ countries including the new Singapore subsidiary.

Differentiator

Problem solved

Functional benefit

Brands

  • GYNELLA: OTC brand covering intimate hygiene, vaginal infections, vaginal atrophy, fertility, and vaginal microflora products including GYNELLA Flora, GYNELLA Balance, GYNELLA AtroGel, GYNELLA Natal Ferti Gel, GYNELLA Silver Caps, GYNELLA Silver Foam, GYNELLA Intimate Foam, GYNELLA Intimate Wash, GYNELLA Girl Intimate Wash, and GYNELLA Cystilab.
  • Gynella
  • Andryll

Products and services

  • GYNELLA Flora

Quantifiable outcome

  • GYNELLA brand launched successfully in 7 European countries
  • +1 more outcomes

Companies that use Heaton Group

Customer profile

Segments3 records

Ideal customer profiles2 records

Heaton Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Heaton Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Active Substance ManufacturerscoreStrategic or Co-development PartnerLong-term partnerships with manufacturers of active substances for product licensing. These partnerships enable Heaton to offer a state-of-the-art portfolio with large production capacity across various pharmaceutical forms including tablets, capsules, gels, foams, and injectable solutions.
  • Distribution PartnerscoreChannel Partner/ Reseller/ DistributorInternational distribution partners operating in various territories with exclusivity arrangements. Current partners cover countries including Austria, Bulgaria, Croatia, Czech Republic, Denmark, UAE, Germany, Malta, Mongolia, Norway, Moldova, Pakistan, Romania, Slovakia, Slovenia.

Scale indicators5 records

Recent moves12 records

Expansion highlights6 records

Heaton Group competitors and assessment

Company assessment

Broad incumbents

  • Perrigo Company: US-headquartered OTC consumer healthcare leader with strong presence in Europe. Direct overlap with Heaton's OTC medical device and women's health positioning through pharmacy distribution.
  • Organon & Co. Global women's health pure-play spun out of Merck in 2021, focused on contraception, fertility, and menopause. Directly addresses the same therapeutic categories as Heaton but at much greater scale and global footprint.
  • Bayer Consumer Health: Global consumer health giant encompassing OTC, women's health, and intimate care products. Heaton's GYNELLA cosmetics/hygiene range overlaps with Bayer's broad feminine care portfolio, though Bayer operates at vastly larger scale.
  • Recordati: Italian specialty pharmaceutical company with strong franchises in urology, gynecology, and rare disease. Comparable in therapeutic focus and geographic mix (European roots expanding globally).

Regional players

  • Polpharma: Polish pharmaceutical manufacturer and one of the largest CEE pharma players. Similar mix of Rx and OTC products, comparable CEE-centric distribution model, and overlapping therapeutic areas including women's health and urology.

Direct peers

  • KRKA: Slovenian-headquartered generic and specialty pharmaceutical company with broad CEE distribution. Comparable scale and origin to Heaton, with overlapping presence in gynecology, urology, and over-the-counter women's health categories.
  • Gedeon Richter: Hungarian-headquartered pharma company with a major women's health franchise (contraception, fertility, menopause). Comparable to Heaton due to CEE origin, prescription + women's health focus, and similar European distribution model.
  • Theramex: UK-headquartered specialty pharmaceutical company exclusively focused on women's health (contraception, fertility, menopause, osteoporosis). Closely comparable as a niche women's health player with similar product categories and OTC/Rx split.
  • STADA Arzneimittel: German-headquartered pharma company with strong generics, specialty, and consumer health businesses. Comparable in European geographic focus and mix of prescription and OTC consumer products including intimate care.

Emerging players

  • Croma-Pharma: Austrian pharmaceutical company specializing in aesthetic medicine, gynecology, and orthopedics with focus on hyaluronic acid-based products. Comparable niche women's health focus and overlapping technology ingredient (hyaluronic acid used in Heaton's GYNELLA AtroGel and Balance).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Heaton Group social profiles

Digital presence

Heaton Group compliance and trust

Trust signal

Compliance7 records

Heaton Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Heaton Group leadership team

Management profile

Number of profiles

Profiles1 record

Heaton Group subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Heaton Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Heaton Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heaton Group

What does Heaton Group do?

Heaton Group supplies prescription pharmaceuticals and OTC medical devices across therapeutic areas including gynecology, urology, nephrology, oncology, diabetology, and hospital care. The company holds more than 30 marketing authorizations for prescription medicines and operates the GYNELLA brand of OTC women's health medical devices (Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, intimate hygiene line), along with cosmetics and foods for special medical purposes. Products are sold in 27 countries through owned sales teams, subsidiaries, and a network of international distribution partners.

Is Heaton Group a public or private company?

Heaton Group is a private company. It is classified as family owned and is currently operating.

When was Heaton Group founded?

Heaton Group was founded in 2002. It employs 51 to 100 people.

Where is Heaton Group based?

Heaton Group is headquartered in Prague, Czechia, in the Europe region.

How does Heaton Group make money?

Four revenue lines are on record. Prescription Medicines are the primary driver. The others are medical Devices (OTC), cosmetics and foods for Special Medical Purposes.

Who are Heaton Group's main competitors?

Broad incumbents on record are Perrigo Company, Organon & Co., Bayer Consumer Health and Recordati. Polpharma is listed as a regional player. Direct peers are KRKA, Gedeon Richter, Theramex and STADA Arzneimittel. Croma-Pharma is listed as an emerging player.

Does Heaton Group have an API?

No public API is recorded for Heaton Group.

What industry is Heaton Group in?

Heaton Group's product category is Pharmaceutical Products. Its primary akta.pro industry code is HLAIADAJ, Women’s Health (OTC Gynecologic), with a secondary code of HLAIADAK, Men’s Health (OTC Urologic & Sexual Health). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals